LIMB GIRDLE MUSCULAR DYSTROPHY
Clinical trials for LIMB GIRDLE MUSCULAR DYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new LIMB GIRDLE MUSCULAR DYSTROPHY trials appear
Sign up with your email to follow new studies for LIMB GIRDLE MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial for rare muscle disease halted after early phase
Disease control TerminatedThis early-stage study aimed to test the safety of a single-dose gene therapy called SRP-9004 for a rare, inherited muscle-wasting disorder. It involved a small group of participants, some who could walk and some who could not, to see if the treatment was safe and if it could inc…
Matched conditions: LIMB GIRDLE MUSCULAR DYSTROPHY
Phase: PHASE1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Early gene therapy trial for rare muscle disease halted
Disease control TerminatedThis early-stage study tested whether a gene therapy called SRP-6004 could safely deliver a working gene to people with limb girdle muscular dystrophy type 2B, a rare genetic muscle disorder. The trial involved just 2 participants who could still walk and had specific genetic mut…
Matched conditions: LIMB GIRDLE MUSCULAR DYSTROPHY
Phase: PHASE1 • Sponsor: Sarepta Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC